Biohaven Shares Fall After RBC Downgrades Stock and Cuts Price Target
Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1. 9% to $15.
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Biohaven"
Tuesday, September 8, 2026
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Biohaven"
Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1. 9% to $15.